What You Should Know about Ortho Evra
The Ortho Evra patch, marketed to young women as an easy an effective form of birth control, is now under scrutiny for its possible connection to several deaths and serious side effects. Ortho Evra was approved by the U.S. Food and Drug Administration (FDA) in November 2001 to prevent unwanted pregnancy by continuously releasing estrogen and progestin into the blood stream. However, several reports to the FDA of life-threatening blood clots and other serious side effects prompted concern over the use of defective Ortho Evra patches. If you have suffered from the severe side effects of this defective patch, contact an experienced lawyer today to learn about your legal rights to compensation in New York. Contact an Ortho Evra Attorney today!
Since the birth control patch was introduced to the public in 2002:
- 44 serious blood-clot related injuries were reported to the FDA in the first year after Ortho Evra’s introduction.
- 17 deaths were reported in the first two years after Ortho Evra’s introduction. There have been 23 deaths to date that have been reported to the FDA.
- 9,116 reports of adverse reactions in a 17-month period were reported by the FDA in November 2005.
As of September 20, 2006, the defective Ortho Evra patch has not been recalled despite these reports. While its labeling has been updated in accordance to the FDA’s instruction, it continues to be prescribed to young women as a form of birth control. If you or someone you know experienced any of the side effects mentioned above while using Ortho Evra, consult with our to discuss your legal right to be compensated for your pain and suffering.
New Warnings Issued
November 2005: Ortho-McNeil, in response to a warning issued by the FDA, updated its medication packaging labels to reflect findings that the contraceptive patch exposes women to 60% more estrogen than oral contraceptives. Elevated exposure to this hormone has been known to increase the chances of serious blood-clot related side effects.
Contact an Ortho Evra Attorney at Finz & Finz, P.C. today for more information on the serious side effects which can occur from using a defective Ortho Evra patch.
September 2006: Two research studies, sponsored by Johnson & Johnson, provided further evidence that women using the Ortho Evra patch are twice as likely to develop blood clots when compared with using oral contraceptives. As a result, the FDA required Ortho-McNeil, the manufacturer of the Ortho Evra birth control patch, to update its warning language, also requesting that it further investigate the risks of blood clots, heart attack and stroke.
Have you, a friend or a loved one suffered side effects from using a defective Ortho Evra patch?
Thousands of cases of adverse side effects have been reported to the FDA since 2002. Reported side effects in New York and nationwide include stroke, heart attack, blood clots, upper respiratory infection, breast symptoms, headache, nausea, menstrual cramps, and a reaction of the site of application.
If you or family member have used the Ortho Evra birth control patch and have suffered from a blood clot, heart attack or stroke, please contact an Ortho Evra Attorney of Finz & Finz, P.C. today at (888) FINZ-FIRM to speak with an experienced defective drug lawyer in New York now or fill out the Free Case Evaluation form.
